Gene Query: PEX10

Dataset Description Geneva Score
Role for citron kinase in prostate cancer growth 113.02
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 84.59
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 84.59
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 69.6
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 57.35
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 51.04
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 50.35
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 43.81
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 38.94
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 38.94
Paxillin regulates genomic networks in prostate cancer [C4-2] 37.71
Dtx3L and Androgen Signaling in Prostate Cancer 32.88
Paxillin regulates genomic networks in prostate cancer [LNCaP] 27.94
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 25.36
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 24.45
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 24.45
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 24.26
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 22.57
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 21.87
Tracing Enhancer Networks using Epigenetic Traits (TENET) 18.87
Lipid degradation promotes prostate cancer cell survival 16.42
LNCaP treated with iBET 14.45
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 12.66
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 12.66
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 12.52
Glioblastoma stem cells infected by ZIKA virus 12.49
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 12.4
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 12.4
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 12.3
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 11.93
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 11.93
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 11.42
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 11.42
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 9.83
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 9.68
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 9.37
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 9.1
Genome-wide functional assessment of enhancer activities in the human genome 8.66
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 8.44
Effect of CHKA knockdown on C4-2 cell transcriptome 8.43
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 8.26
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 8.14
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 8.14
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 7.91
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 7.91
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 7.77
Transcriptome profiling of Normal and Cancerous Prostate Cells 7.64
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 7.32
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 6.51
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 6.39
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 6.32
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 6.06
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 5.91
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 5.87
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 5.35
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 5.35
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 5.31
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 5.3
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 5.29
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 5.26
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 5.23
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 5.11
MARS Seq data from human cortical organoids 5.03
Transcriptome of U251 cells overexpression complement component 7 4.96
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 4.88
HNRNPL and its RNA Targets in Prostate Cancer 4.88
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 4.88
Identification of HOXB13 target genes responsive to BET inhibitors 4.87
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 4.87
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 4.86
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 4.67
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 4.6
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 4.52
Cleavage Factor Im as a key regulator of 3’ UTR length 4.51
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 4.43
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 4.25
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 4.25
The regulartory role of ZCCHC24 in splicing machinery 4.22
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 4.17
Comparing gene expression in iPSC derived RPE from control and AMD donors 4.17
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 4.16
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 4.11
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 4.08
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 4.0
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 3.94
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 3.87
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.83
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 3.75
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 3.67
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 3.61
hTERT promotes cell adhesion and migration independent of telomerase activity 3.58
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 3.56
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 3.49
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 3.39
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 3.39
MYCi975 regulates MYC target genes 3.39
Novel Targeting of Transcription and Metabolism in Glioblastoma 3.37
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 3.36
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 3.34
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 3.31
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 3.31
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.3
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.3
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 3.17
CDK4/6 inhibitor resistance in prostate cancer 3.12
CD73 knockdown effect in pancreatic cancer cell lines 3.0
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 2.98
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 2.95
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 2.95
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 2.95
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 2.93
Gene expression analysis of the impact of TDP-43 knockout in human cells. 2.92
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 2.88
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.86
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 2.85
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 2.85
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 2.83
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 2.78
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 2.7
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.7
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.69
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.68
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.68
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 2.66
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 2.66
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 2.58
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 2.58
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 2.57
Gene expression analysis upon mtDNA depletion 2.57
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.57
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 2.56
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 2.53
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 2.5
RNA-Seq with and without RNase treatment in PCa cell lines 2.49
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 2.48
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 2.48
Nutritional control of protein translation 2.48
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 2.46
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 2.43
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 2.43
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 2.4
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.35
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 2.35
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 2.34
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 2.33
Patient-derived luminal breast cancer xenografts with progestins 2.33
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 2.32
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.32
Genome wide expression change by RNF168 knocking down in NEC cells 2.32
Gene expression in GBM with Cav3.2 inhibition 2.28
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 2.27
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 2.25
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.24
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 2.24
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 2.19
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 2.19
Iron response of HepG2 cells 2.17
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 2.16
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 2.16
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 2.16
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 2.15
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 2.15
RNA sequencing of mechanically strained NHEKs and control NHEKs 2.14
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 2.13
Differentiation enhances Zika virus infection in neuronal brain cells 2.12
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.11
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 2.1
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 2.08
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 2.08
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 2.08
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 2.07
MeRIP-seq for heat shock in B-cell lymphoma cells 2.07
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 2.03
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 2.03
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 2.02
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 2.02
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 2.01
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 2.01
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 2.0
Genetic-to-epigenetic Therapy for Pancreatic Cancer 1.98
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.95
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 1.93
HEXIM1 is induced by DHODH inhibition to suppress melanoma 1.93
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 1.93
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 1.92
A prostate cancer chromatin interaction map 1.91
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 1.91
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 1.89
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 1.89
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 1.89
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 1.88
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 1.87
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.86
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 1.86
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 1.86
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 1.85
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 1.81
High-Throughput Kinetic Analysis of Fractional Killing 1.79
AR-independent prostate cancer is sustained through FGF signaling 1.78
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 1.76
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 1.76
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 1.75
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 1.75
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 1.74
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 1.72
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 1.72
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 1.71
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 1.71
RNAseq of cell lines with knocked in ESR1 mutations 1.69
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 1.67
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 1.66
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 1.65
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.65
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 1.64
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 1.63
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 1.63
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 1.63
Global analysis of alternative splicing regulated by RBM10 1.62
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.6
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 1.6
Transcriptome analysis of SKI knock-out in HL60 cells 1.6
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 1.6
Global Mapping of Human RNA-RNA Interactions 1.59
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.59
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.58
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 1.57
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 1.57
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 1.57
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.56
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.56
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.56
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.56
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 1.54
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 1.52
HEK293 TFAM Knockout Expression Study 1.52
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 1.52
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.51
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.51
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.5
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 1.48
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 1.46
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 1.46
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 1.45
Genome-wide Analysis of Chromatin Interactions in Human Cells 1.45
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 1.43
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 1.43
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.42
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.42
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.42
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 1.41
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 1.41
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.41
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 1.41
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.41
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 1.4
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.4
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.4
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 1.39
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 1.38
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 1.38
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 1.37
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.34
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.34
Effect of disulfiram treatment on pediatric high grade glioma 1.32
Age-Related Gene Expression Changes in Prostate Cancer Patients 1.31
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 1.31
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.31
The effect of insulin on mRNA transcription of human pluripotent stem cells 1.31
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 1.28
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 1.28
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.27
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.27
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 1.26
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 1.26
Ribosomal protein RPL26 is the principal target of UFMylation 1.26
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 1.25
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 1.25
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.24
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.24
Functional role of CPPED1 in trophoblasts. 1.24
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 1.24
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 1.21
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.19
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.18
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 1.16
Altering cancer transcriptomes using epigenomic inhibitors 1.16
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 1.16
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.15
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.13
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 1.12
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 1.12
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 1.11
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.1
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.1
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 1.08
H1609088 Human RNA-Sequencing 1.07
High-throughput sequencing of pluripotent cells 1.07
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 1.06
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.05
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.05
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.04
Hijacking of stress response machinery by oncogenes in acute leukaemia 1.03
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 1.03
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 1.02
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 1.02
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.01
Cajal bodies are linked to genome conformation [RNA-Seq] 1.01
Cajal bodies are linked to genome conformation 1.01
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 1.01
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 1.01
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 1.01
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 1.0
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.99
Differential responses of human fetal brain neural stem cells to Zika virus infection 0.98
Discovering human diabetes-risk gene function with genetics and physiological assays 0.97
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 0.97
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.97
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 0.97
Loss of CREBBP results in gene expression repression in lymphoma cells 0.97
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.97
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 0.96
Androgen Receptor-regulated genes in prostate cancer cells 0.96
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.96
Effect of FGF13 depletion on the H460 cell line 0.95
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.93
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 0.91
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.89
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 0.89
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.88
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.88
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.88
Measure transcript integrity using RNA-seq data 0.88
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.87
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.87
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 0.85
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 0.85
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.84
Investigate A2M treatment on human prostate cancer and mouse liver 0.84
Investigate A2M treatment on human prostate cancer xenograft in mice 0.84
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.82
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.81
N6-methyladenine DNA Modification in Glioblastoma 0.81
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 0.8
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.79
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 0.79
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.79
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 0.78
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.78
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 0.77
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.77
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.76
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.76
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.76
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.75
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 0.75
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 0.73
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 0.73
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.72
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.72
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.71
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.7
RNA-Sequencing of HepG2 cells treated with TGFBeta 0.7
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 0.69
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 0.69
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.69
Genome-wide analysis of the Integrator complex (HTS) 0.69
Genome-wide analysis of the Integrator complex 0.69
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 0.68
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.67
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.66
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 0.64
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 0.64
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.62
Ebola virus (EBOV) infection of ARPE-19 cells 0.62
RNA editing in nascent RNA affects pre-mRNA splicing 0.61
PTHrP overexpression in MCF7 cells 0.61
Functional significance of the HIV-1 Tat signature amino acid residues 0.61
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.61
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.61
A transcriptome-wide divergence in protein translation scales with LIN28B expression 0.6
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.6
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.6
SF3B1 Degron knockdown RNA-seq 0.6
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 0.59
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.59
RNA-seq in transgenic cells 0.58
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.58
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.58
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.58
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.58
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.58
Dissecting neural differentiation regulatory networks through epigenetic footprinting 0.57
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.55
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.54
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 0.53
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 0.53
EGR1-controlled transcriptome of T HESCs 0.52
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 0.51
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.51
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 0.51
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.5
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.5
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.5
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.49
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.48
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.47
Induced DNA demethylation, genome instability and transcription 0.47
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.46
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 0.46
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 0.46
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 0.44
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.44
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 0.43
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.42
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.41
Metastasis in triple-negative breast cancer 0.41
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.41
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 0.4
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 0.4
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.4
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.4
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.4
UV_24h_GRO-Seq 0.39
Microglia innatly develop within cerebral organoids 0.39
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.38
The circadian transcriptional landscape in primary human mammary epithelial cells 0.38
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 0.38
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.38
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.38
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.38
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 0.37
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 0.37
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.35
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.34
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 0.34
Co-regulation of splicing by Rbfox1 and hnRNP M 0.34
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.33
RNA-Seq and expression data from human adipose tissue 0.32
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.32
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.32
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.32
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 0.32
Role of FGFR1 in neuronal devlopment 0.31
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 0.31
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.3
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.26
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.26
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 0.25
Comparative Analysis of Cas9 Activators Across Multiple Species 0.25
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 0.24
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 0.24
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.23
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.23
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 0.22
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.2
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.2
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.2
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.2
SRSF1 role in cellular gene expression and splicing 0.2
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.2
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.17
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.17
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.17
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.16
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.15
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.15
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.15
Illumina Total RNA-seq in HeLa 0.14
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.14
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.13
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.13
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.13
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.13
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.12
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.12
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.12
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.1
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 0.1
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 0.09
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.09
miRNAs affected by antagomiR-17 treatment 0.09
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 0.09
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.09
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 0.09
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 0.09
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.08
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.07
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.06
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.06
HNRNPM-regulated splicing dependencies in prostate cancer 0.06
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.06
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.06
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.06
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.05
Direct Isolation and Characterization of Human Nephron Progenitors. 0.05
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.04
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.04
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.04
The role of the Calcium-Sensing receptor in colorectal cancer 0.01
Gene expression changes in human melanoma cell lines compared to primary melanocytes 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation